Cargando…
Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1- and G6PC-mediated gluconeogenesis
Type 2 diabetes (T2D) is often accompanied with an induction of retinaldehyde dehydrogenase 1 (RALDH1 or ALDH1A1) expression and a consequent decrease in hepatic retinaldehyde (Rald) levels. However, the role of hepatic Rald deficiency in T2D progression remains unclear. In this study, we demonstrat...
Autores principales: | Yang, Hanyu, Su, Mengxiang, Liu, Ming, Sheng, Yun, Zhu, Liang, Yang, Lu, Mu, Ruijing, Zou, Jianjun, Liu, Xiaodong, Liu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501888/ https://www.ncbi.nlm.nih.gov/pubmed/37719384 http://dx.doi.org/10.1016/j.apsb.2023.06.014 |
Ejemplares similares
-
SHP-1 phosphatase acts as a coactivator of PCK1 transcription to control gluconeogenesis
por: Kumar, Amit, et al.
Publicado: (2023) -
NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression
por: Tsujimoto, Goki, et al.
Publicado: (2022) -
Generation of Retinaldehyde for Retinoic Acid Biosynthesis
por: Belyaeva, Olga V., et al.
Publicado: (2019) -
Senotherapeutic Effect of Retinaldehyde and Hyaluronate Fragments in Dermatoporosis
por: Kaya, Aysin, et al.
Publicado: (2023) -
Deficiency of Retinaldehyde Dehydrogenase 1 Induces BMP2 and Increases Bone Mass In Vivo
por: Nallamshetty, Shriram, et al.
Publicado: (2013)